Global Bone Growth Stimulator Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
MarketResearch.biz delivers in-depth insights on the global bone growth stimulator market in its upcoming report titled, “Global Bone Growth Stimulator Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027”. The global bone growth stimulator market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global bone growth stimulator market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global bone growth stimulator market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global bone growth stimulator market report has been segmented on the basis of product, application, end-user, and region.
A bone growth stimulator is a supplemental device worn to induce new bone growth after spine surgeries such as cervical (neck) or lumbar (low back) spine surgery. Bone growth stimulators are of two types, internal bone growth stimulator & external bone growth stimulator. An internal bone growth stimulator is implanted at the time of fusion surgery and external stimulator is worn against the skin. In some cases, bone injuries and spinal fusion surgery have difficulty in healing, in order to overcome these injuries physicians, recommend bone growth stimulator treatment.
Rising demand for minimal invasive and non-invasive treatment and increasing prevalence of arthritis and sports related injuries are key factors driving growth of the global bone growth stimulator market. In addition, product enhancement, technological development, and rising number of accidents and incidences of orthopedic trauma are other factors fueling growth of the global bone growth stimulator market.
However, product defectiveness and availability of alternative therapies such as bone grafting are key factors hampering growth of the global bone growth stimulator market. Additionally, side effects associated with overconsumption bone morphogenetic protein (BMP) – a protein that stimulates bone growth – and high cost of product are other major factors expected to hamper growth of the global bone growth stimulator market.
The market in North America dominates the global bone growth stimulator market in terms of revenue owing to increasing prevalence of orthopedic diseases, high awareness about the treatment among individuals, and increasing adoption of novel treatment. The market in Europe is currently the second-highest market in the global bone stimulator market. The market in Asia Pacific is expected to witness fastest growth in terms of revenue, and is expected to register a CAGR of X.X% during the forecast period. This growth can be attributed to increasing awareness among individuals and healthcare professionals and increasing investments in healthcare infrastructure.
Global Bone Growth Stimulator Market Segmentation:
Global bone growth stimulator market segmentation by product:
- Bone growth stimulation devices
- Bone morphogenetic protein
- Platelet-rich plasma
Global bone growth stimulator market segmentation by application:
- Spinal fusion surgeries
- Delayed union and nonunion bone fractures
- Oral and maxillofacial surgeries
Global bone growth stimulator market segmentation by end user:
- Hospitals and clinics
- Home care
Global bone growth stimulator market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Estimated Year 2020 Actual Year 2021 Forecast Period 2021–2030 Revenue in US$
- Medtronic plc
- Zimmer Biomet Holdings, Inc.
- DJO Finance LLC
- Bioventus LLC
- Stryker Corporation
- DePuy Synthes
- Arthrex, Inc.
- Isto Biologics
- Orthofix Holdings, Inc.
- Terumo BCT, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!